The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells

The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulent M.tb in a ‘challenge’ experiment following vacci...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Tanner, R, Hoogkamer, E, Bitencourt, J, White, A, Boot, C, Sombroek, CC, Harris, SA, O'Shea, MK, Wright, D, Wittenberg, R, Sarfas, C, Satti, I, Verreck, FAW, Sharpe, SA, Fletcher, HA, McShane, H
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	F1000Research 2021

Παρόμοια τεκμήρια

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
ανά: Tanner, R, κ.ά.
Έκδοση: (2021)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
ανά: Rachel Tanner, κ.ά.
Έκδοση: (2021-01-01)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
ανά: Pepponi, I, κ.ά.
Έκδοση: (2017)

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
ανά: Brennan, M, κ.ά.
Έκδοση: (2017)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
ανά: Tanner, R, κ.ά.
Έκδοση: (2020)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
ανά: Tanner, R, κ.ά.
Έκδοση: (2021)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
ανά: Painter, H, κ.ά.
Έκδοση: (2024)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
ανά: Harris, S, κ.ά.
Έκδοση: (2017)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
ανά: Mcshane, H, κ.ά.
Έκδοση: (2017)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
ανά: Marsay, L, κ.ά.
Έκδοση: (2013)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
ανά: Alvarez, MPP, κ.ά.
Έκδοση: (2024)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
ανά: Marsay, L, κ.ά.
Έκδοση: (2013)

Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
ανά: Naranbhai, V, κ.ά.
Έκδοση: (2015)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
ανά: O'Shea, M, κ.ά.
Έκδοση: (2018)

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates
ανά: Marco Polo Peralta Alvarez, κ.ά.
Έκδοση: (2024-05-01)

A review of clinical models for the evaluation of human TB vaccines.
ανά: O'Shea, M, κ.ά.
Έκδοση: (2016)

Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients
ανά: Ongarj, J, κ.ά.
Έκδοση: (2024)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
ανά: Tanner, R
Έκδοση: (2015)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
ανά: Tanner, R, κ.ά.
Έκδοση: (2017)

Gene expression and cytokine profile correlate with mycobacterial growth in a human BCG challenge model
ανά: Matsumiya, M, κ.ά.
Έκδοση: (2014)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
ανά: Meyer, J, κ.ά.
Έκδοση: (2013)

Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination
ανά: Bitencourt, J, κ.ά.
Έκδοση: (2021)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
ανά: Meyer, J, κ.ά.
Έκδοση: (2013)

MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates
ανά: Peralta-Álvarez, MP, κ.ά.
Έκδοση: (2024)

Cytomegalovirus infection is a risk factor for TB disease in infants
ανά: Müller, J, κ.ά.
Έκδοση: (2019)

The characterisation of mycobacterial control profiles and underlying immune signatures in patients with latent tuberculosis infection and active disease
ανά: O'Shea, M
Έκδοση: (2016)

Glycomimetic inhibitors of mycobacterial glycosyltransferases: targeting the TB cell wall.
ανά: Lucas, R, κ.ά.
Έκδοση: (2008)

Non-TB mycobacterial infections in patients with non-CF bronchiectasis
ανά: M Mirsaeidi, κ.ά.
Έκδοση: (2015-01-01)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
ανά: McNeill, E, κ.ά.
Έκδοση: (2018)

Quantitative Rapid Test for Detection and Monitoring of Active Pulmonary Tuberculosis in Nonhuman Primates
ανά: Zijie Zhou, κ.ά.
Έκδοση: (2021-12-01)

Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection
ανά: Matthew K. O'Shea, κ.ά.
Έκδοση: (2018-12-01)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
ανά: O'Shea, M, κ.ά.
Έκδοση: (2018)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
ανά: Painter, H, κ.ά.
Έκδοση: (2024)

Using aerosol Bacille Calmette-Guérin in non-human primates to model the immune response to Mycobacterium Tuberculosis: a translational bridge between preclinical models and clinical trials
ανά: Hoogkamer, E
Έκδοση: (2022)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
ανά: Hannah Painter, κ.ά.
Έκδοση: (2024-02-01)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
ανά: Riste, M, κ.ά.
Έκδοση: (2021)

Risk factors for atypical mycobacterial disease in patients with smear positive pulmonary TB
ανά: Hany Shaarawy, κ.ά.
Έκδοση: (2014-07-01)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
ανά: Thomas, Z, κ.ά.
Έκδοση: (2014)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
ανά: Fletcher, H, κ.ά.
Έκδοση: (2013)

The fall of the mycobacterial cell wall: interrogating peptidoglycan synthesis for novel anti-TB agents
ανά: Cheng-Yu Chiang, κ.ά.
Έκδοση: (2024-11-01)